Rznomics
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Innovalley C Dong unit 801 Pangyo-ro 253...Website
www.rznomics.comRevenue
$6 MillionIndustry
About Rznomics
Rznomics specializes in the development of innovative RNA-based biopharmaceuticals aimed at addressing various unmet medical needs, particularly in the fields of cancer, degenerative diseases, and genetic disorders. The company focuses on gene therapy development for conditions such as liver cancer, brain tumors, Alzheimer's disease, and retinitis pigmentosa. With a strong emphasis on RNA platform technology, Rznomics aims to pioneer new modalities in RNA therapy through catalytic RNA rewriting. Their expertise lies in modular engineering and high-performance RNA targeting specific to disease-related pathways.Explore more
Rznomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Rznomics Tech Stack
A closer look at the technologies used by Rznomics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rznomics
Sign Up For FreeTo access detailed company insights
Rznomics specializes in the development of innovative RNA-based biopharmaceuticals aimed at addressing various unmet medical needs, particularly in the fields of cancer, degenerative diseases, and genetic disorders. The company focuses on gene therapy development for conditions such as liver cancer, brain tumors, Alzheimer's disease, and retinitis... Read More
